Eukles Asset Management’s Medtronic MDT Stock Holding History

Eukles Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,206	Closed	-$150K	–	224
2021 Q2	$150K	Buy	+1,206	New	+$151K	0.08%	109
2020 Q4	–	Sell	-17	Closed	-$2K	–	161
2020 Q3	$2K	Sell	17 -18,073	-100%	-$1.82M	﹤0.01%	144
2020 Q2	$1.66M	Buy	18,090 +2,522	+16%	+$242K	1.41%	27
2020 Q1	$1.4M	Sell	15,568 -2,738	-15%	-$291K	1.46%	26
2019 Q4	$2.08M	Sell	18,306 -80	-0.4%	-$8.78K	1.69%	21
2019 Q3	$2M	Sell	18,386 -140	-0.8%	-$14.6K	1.73%	18
2019 Q2	$1.8M	Sell	18,526 -254	-1%	-$23.2K	1.57%	20
2019 Q1	$1.71M	Hold	18,780	–	–	1.56%	23
2018 Q4	$1.71M	Buy	+18,780	New	+$1.75M	1.78%	17

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eukles Asset Management's MDT Position: Q3 2021 in Review

Eukles Asset Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 1,206 shares — an estimated $150K sold.

Eukles Asset Management first reported a position in MDT in Q4 2018 and held it in 9 quarters. The position peaked at $2.08M in Q4 2019. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Eukles Asset Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
Eukles Asset Management sold 1,206 Medtronic shares in Q3 2021, an estimated $150K.
Eukles Asset Management first reported a position in Medtronic in Q4 2018 and held it in 9 quarters.
Eukles Asset Management's Medtronic position peaked at $2.08M in Q4 2019.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Eukles Asset Management's 13F filing for Q3 2021, filed 28 Oct 2021.